TENET HEALTHCARE CORP

Tenet Healthcare (THC) Registers a Bigger Fall Than the Market: Important Facts to Note

Tenet Healthcare (THC) closed the most recent trading day at $260.85, moving 1.38% from the previous trading session.

Tenet Healthcare Shares Fall 2.3% After Director Sells $2.63 Million of Stock

Tenet Healthcare Corporation (NYSE:THC) shares fell 2. 3% in premarket trading on Tuesday after a regulatory filing showed that director Richard Mark sold 10,000 shares in the healthcare company.

$100 Invested In Tenet Healthcare 5 Years Ago Would Be Worth This Much Today

Tenet Healthcare (NYSE:THC) has outperformed the market over the past 5 years by 17.9% on an annualized basis producing an average annual return of 29.4%. Currently, Tenet Healthcare has a market capitalization of

Here's Why Tenet Healthcare Shares are Attracting Investors Now

THC's shares are gaining on higher-acuity demand, strong commercial revenues and USPI's continued expansion.

Tenet Healthcare and Archrock have been highlighted as Zacks Bull and Bear of the Day

Tenet Healthcare's strong Q2, rising EPS estimates and modest valuation contrast with Archrock's misses and falling outlook.

Tenet Healthcare (NYSE:THC): Undervalued With Strong Profitability

Tenet Healthcare (THC) offers strong value with low P/E, high profitability, and sound liquidity, making it a solid pick for disciplined value investors.

Tenet Healthcare (THC) Price Target Increased by 16.59% to 284.25

Tenet Healthcare (THC) Stock Still Looks Cheap On Earnings

Tenet Healthcare has delivered a very strong 270.6% return over the past 5 years, so the key issue for investors now is whether the current price still lines up with what the valuation checks suggest about the stock. The 270.6% 5 year return highlights how much expectations have shifted and raises the bar for any further gains to be supported by fundamentals. Recent optimism around revenue growth and margin execution can support the current valuation, while any setback in managing costs or...

Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $281

Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $231 to $281.

Tenet Healthcare Tops Q2 Earnings Estimates, Raises 2026 Outlook

THC raised its 2026 outlook after Q2 earnings and revenues beat expectations, driven by strong same-facility growth and disciplined expense management.